Scapuloperoneal spinal muscular atrophy (SPSMA) is one of several neuromuscular disorders associated with the human TRPV4 gene. See the human disease model report for neuromuscular diseases, TRPV4-related (FBhh0001240) for information on experimental results using Drosophila models of this and related diseases.
UAS constructs of the human Hsap\TRPV4 gene have been introduced into flies, including wild-type and variants implicated in disease. Variant(s) implicated in human disease tested (as transgenic human gene, TRPV4): the R269C variant form of the human gene has been introduced into flies. This variant is also implicated in HMSN2C and HMN8.
[updated Aug. 2020 by FlyBase; FBrf0222196]
[SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA](https://omim.org/entry/181405)
[TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY V, MEMBER 4; TRPV4](https://omim.org/entry/605427)
Features of this variable clinical disorder include congenital absence of muscles, progressive scapuloperoneal atrophy, laryngeal palsy, and progressive distal weakness and amyotrophy. Individuals within the same family may present with different phenotypes. [from MIM:181405; 2020.08.16]
Scapuloperoneal spinal muscular atrophy (SPSMA) is caused by heterozygous mutation in the TRPV4 gene. [from MIM:181405; 2020.08.16]
Many to many: multiple related genes in both species.